April 19, 2018 12:38 PM ET


Company Overview of Baliopharm AG

Company Overview

Baliopharm AG operates as a biotechnology company that focuses on the development of novel therapeutics for the treatment of immune mediated inflammatory diseases and cancer. The company was incorporated in 2007 and is headquartered in Basel, Switzerland with a subsidiary in Jülich, Germany. As of April 10, 2018, Baliopharm AG operates as a subsidiary of PROMETHERA Biosciences S.A./N.V.

Stänzlergasse 4

Basel,  4051


Founded in 2007


41 61 2053 910


41 61 2053 919

Key Executives for Baliopharm AG

Chief Executive Officer
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
4bases S.A. Europe
AB2 Bio Ltd. Europe
ADC Products Switzerland SARL Europe
ADC Therapeutics SA Europe
AlloCyte Pharmaceuticals AG Europe

Recent Private Companies Transactions

April 10, 2018

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Baliopharm AG, please visit www.baliopharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.